Published in Support Care Cancer on September 07, 2012
Physiological changes after fluid bolus therapy in sepsis: a systematic review of contemporary data. Crit Care (2014) 1.44
Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE. Crit Care (2016) 1.04
Early management of sepsis with emphasis on early goal directed therapy: AME evidence series 002. J Thorac Dis (2017) 0.75
Comparison of diagnostic and prognostic utility of lactate and procalcitonin for sepsis in adult cancer patients presenting to emergency department with systemic inflammatory response syndrome. Turk J Emerg Med (2016) 0.75
Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review. ESMO Open (2016) 0.75
Importance of Pharmacy Involvement in the Treatment of Sepsis. Hosp Pharm (2017) 0.75
Identification of the severe sepsis patient at triage: a prospective analysis of the Australasian Triage Scale. Emerg Med J (2014) 0.75
Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med (2001) 51.99
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med (2006) 23.62
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51
Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA (2010) 8.09
Deaths: final data for 2006. Natl Vital Stat Rep (2009) 6.89
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest (2008) 6.25
Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med (2004) 5.64
Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest (2006) 5.31
Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med (2006) 4.62
Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med (2009) 4.56
Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med (2005) 4.49
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med (1998) 4.48
Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med (2007) 4.42
Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med (2006) 4.10
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest (2002) 3.98
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med (2001) 3.95
Barriers to implementing protocol-based sepsis resuscitation in the emergency department--results of a national survey. Crit Care Med (2007) 3.28
Factors associated with nonadherence to early goal-directed therapy in the ED. Chest (2010) 3.23
Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Crit Care Med (2006) 3.18
An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer (2004) 3.06
Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock (2009) 2.59
Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis. Crit Care Med (2009) 2.57
Use of goal-directed therapy for severe sepsis and septic shock in academic emergency departments. Crit Care Med (2005) 2.03
Early goal-directed therapy: can the emergency department deliver? Emerg Med J (2010) 2.01
Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med (2008) 1.93
Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med (2007) 1.88
Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med (2007) 1.88
The epidemiology of sepsis in patients with malignancy. Chest (2006) 1.87
One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study. Crit Care (2009) 1.57
Improved survival of critically ill cancer patients with septic shock. Intensive Care Med (2003) 1.49
Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care (2004) 1.46
Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours. Cancer Biol Ther (2010) 1.40
A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. Chest (2005) 1.39
Impact of the Surviving Sepsis Campaign on the recognition and management of severe sepsis in the emergency department: are we failing? Emerg Med J (2010) 1.16
Failure to implement evidence-based clinical guidelines for sepsis at the ED. Am J Emerg Med (2006) 1.12
Early goal-directed therapy (EGDT) for severe sepsis/septic shock: which components of treatment are more difficult to implement in a community-based emergency department? J Emerg Med (2011) 1.07
Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med (2000) 1.03
Implementing a collaborative protocol in a sepsis intervention program: lessons learned. Lung (2010) 0.88
Standardization of severe sepsis management: a survey of methodologies in academic and community settings. J Emerg Med (2008) 0.78
Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology (2009) 4.72
Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol (2008) 2.53
Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res (2012) 2.17
Tumor-specific changes in mtDNA content in human cancer. Int J Cancer (2005) 1.70
Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci U S A (2012) 1.66
A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg (2009) 1.61
Extended transsternal thymectomy for the treatment of ocular myasthenia gravis. Ann Thorac Surg (2011) 1.58
Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings of a prospective, longitudinal cohort study. Cancer (2015) 1.56
Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest (2011) 1.54
Clinical outcome of juvenile myasthenia gravis after extended transsternal thymectomy in a chinese cohort. Ann Thorac Surg (2013) 1.51
Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer (2014) 1.49
Serum protein profiles in myasthenia gravis. Ann Thorac Surg (2009) 1.39
Roles of COP9 signalosome in cancer. Cell Cycle (2011) 1.37
Access to palliative care among patients treated at a comprehensive cancer center. Oncologist (2012) 1.34
Targeted agent use in cancer patients at the end of life. J Pain Symptom Manage (2012) 1.22
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev (2014) 1.17
Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer (2014) 1.14
Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res (2007) 1.14
CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6. Cell Cycle (2012) 1.12
HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle (2012) 1.11
14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res (2010) 1.11
Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. J Palliat Med (2013) 1.10
Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage. Mol Cancer (2010) 1.06
CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity. Cell Cycle (2013) 0.99
Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer (2012) 0.99
FBXW7 is involved in Aurora B degradation. Cell Cycle (2012) 0.98
Validation of the Edmonton Symptom Assessment System in Korean patients with cancer. J Pain Symptom Manage (2013) 0.96
Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings. Cancer (2014) 0.96
Demographic and clinical determinants of having do not resuscitate orders in the intensive care unit of a comprehensive cancer center. J Palliat Med (2010) 0.93
Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress. BMC Gastroenterol (2013) 0.93
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Ann Intern Med (2016) 0.92
Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer. Oncologist (2013) 0.91
Peripheral arterial occlusive disease: magnetic resonance imaging and the role of aggressive medical management. World J Surg (2007) 0.90
Clinical characteristics of cancer patients referred early to supportive and palliative care. J Palliat Med (2013) 0.89
High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. J Pain Symptom Manage (2013) 0.87
Socioeconomic factors and the presentation, management, and outcome of patients with differentiated thyroid carcinoma. Thyroid (2002) 0.87
Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations. Cancer Metab (2013) 0.85
Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report. Support Care Cancer (2012) 0.84
Association between supportive care interventions and patient self-reported depression among advanced cancer outpatients. Support Care Cancer (2013) 0.81
Experience of barriers to pain management in patients receiving outpatient palliative care. J Palliat Med (2013) 0.81
Medical management of peripheral arterial disease: a therapeutic algorithm. J Endovasc Ther (2006) 0.80
Predictors of response to palliative care intervention for chronic nausea in advanced cancer outpatients. Support Care Cancer (2013) 0.79
Aneurysmal bone cyst in the first rib. Ann Thorac Surg (2008) 0.78
Severe thrombosis and acute thrombocytopenia in a cancer patient. Am J Hematol (2010) 0.78
Modulation of parathyroid hormone-related protein levels (PTHrP) in anaplastic thyroid cancer. Surgery (2005) 0.77
High prevalence of cardiometabolic risk factors in Hispanic adolescents: correlations with adipocytokines and markers of inflammation. J Immigr Minor Health (2014) 0.77
Acute Respiratory Failure Induced by Magnesium Replacement in a 62-Year-Old Woman with Myasthenia Gravis. Tex Heart Inst J (2015) 0.75
Pneumopericardium. CMAJ (2008) 0.75
Pulmonary well-differentiated fetal adenocarcinoma with platelet-derived growth factor receptor (PDGFR)α expression. Cancer Biol Ther (2012) 0.75
Multiple cystic sweat gland tumors in transgenic mice. Comp Med (2012) 0.75
Characteristics and outcomes of advanced cancer patients who miss outpatient supportive care consult appointments. Support Care Cancer (2014) 0.75
1465: TIMING TO ANTIBIOTIC THERAPY IN SEPTIC ONCOLOGIC PATIENTS PRESENTING WITHOUT HYPOTENSION. Crit Care Med (2016) 0.75
Problem-based review: Immune-mediated complications of 'Checkpoint Inhibitors' for the Acute Physician. Acute Med (2017) 0.75